HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Experimental Chemotherapy

Experimental Chemotherapy

Experimental chemotherapy represents an innovative frontier in cancer research, aiming to enhance treatment efficacy while minimizing adverse effects. This cutting-edge approach involves the exploration of novel drugs, combination therapies, and targeted delivery systems. Researchers are delving into personalized chemotherapy regimens tailored to individual genetic profiles, potentially maximizing therapeutic outcomes. Moreover, experimental chemotherapy encompasses the development of immunotherapy agents that harness the body's immune system to combat cancer cells selectively. By pushing the boundaries of traditional chemotherapy, scientists strive to overcome drug resistance, reduce toxicity, and improve overall patient survival rates. While still in the experimental stages, these advancements hold promise for revolutionizing cancer treatment paradigms, offering hope for more effective and tolerable therapies in the fight against cancer.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp